TIDES: Oligonucleotide and Peptide Therapeutics is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa

Markus Mandler, PhD
CSO at Accanis Biotech

Profile

Dr. Mandler is CSO of ACCANIS, bringing with him over 10 years of collaborative research and management experience spanning academia and industry. He completed his PhD at Boehringer Ingelheim´s Institute of Molecular Pathology in Vienna in 2003 working on skin development and especially focused on appendages including hair, feathers, and teeth. Dr. Mandler is the former head of the Neurodegeneration Department at AFFiRiS where he was responsible for developing several immunotherapeutics from preclinic into early clinical development. He has authored numerous publications in high impact journals, several patents and has received multiple national and international research grants for his work.

Markus Mandler, PhD's Network

Agenda Sessions

  • Evaluation of Modified Interferon alpha mRNA Constructs for the Treatment of Non-melanoma Skin Cancer

    , 8:50am